Google DeepMind Unveils AlphaGenome DNA Prediction Model
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
AI coverage of health and biotechnology, tracking deployments, deals, and policy shaping care delivery, drug discovery, and biomedical research.
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.